Media Healthcare Sector

Bicara Therapeutics

Market Cap: US$544.3m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Mind Medicine (MindMed)

Market Cap: US$539.5m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

Eton Pharmaceuticals

Market Cap: US$537.4m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Enhabit

Market Cap: US$529.2m

Provides home health and hospice services in the United States.

LifeMD

Market Cap: US$524.5m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

OrthoPediatrics

Market Cap: US$523.1m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Upstream Bio

Market Cap: US$517.5m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Axogen

Market Cap: US$514.6m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

Owens & Minor

Market Cap: US$504.9m

Operates as a healthcare solutions company worldwide.

Community Health Systems

Market Cap: US$501.6m

Owns, leases, and operates general acute care hospitals in the United States.

Stoke Therapeutics

Market Cap: US$501.2m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Talkspace

Market Cap: US$493.6m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

Maze Therapeutics

Market Cap: US$490.5m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Relay Therapeutics

Market Cap: US$488.6m

Operates as a clinical-stage precision medicines company.

Arvinas

Market Cap: US$488.3m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Kura Oncology

Market Cap: US$485.7m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

EyePoint Pharmaceuticals

Market Cap: US$484.4m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

Semler Scientific

Market Cap: US$483.9m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Auna

Market Cap: US$483.8m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Definitive Healthcare

Market Cap: US$480.0m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Botanix Pharmaceuticals

Market Cap: AU$745.1m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Capricor Therapeutics

Market Cap: US$479.0m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

SBC Medical Group Holdings

Market Cap: US$476.6m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Tyra Biosciences

Market Cap: US$469.0m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Verastem

Market Cap: US$468.2m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Theravance Biopharma

Market Cap: US$464.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

Allergy Therapeutics

Market Cap: UK£343.2m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Zevra Therapeutics

Market Cap: US$462.0m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Cullinan Therapeutics

Market Cap: US$461.5m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Castle Biosciences

Market Cap: US$456.2m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

REGENXBIO

Market Cap: US$455.0m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Sana Biotechnology

Market Cap: US$451.1m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

PYC Therapeutics

Market Cap: AU$699.9m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Claritev

Market Cap: US$450.4m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.